Vimarsana
Biggest News Aggregation in the World

Page 5 - Chief Science News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Stay updated with breaking news from Chief Science. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Top News In Chief Science Today - Breaking & Trending Today

Perspective Therapeutics to Host In-Person and Virtual Analyst Day to Discuss Targeted Alpha-Particle Radiotherapy for Cancer on March 18, 2024 - Vimarsana News

Perspective Therapeutics to Host In-Person and Virtual Analyst Day to Discuss Targeted Alpha-Particle Radiotherapy for Cancer on March 18, 2024

SEATTLE, March 11, 2024 -- Perspective Therapeutics, Inc. , a radiopharmaceutical company that is pioneering advanced treatment applications for cancers throughout the body, today announced that...

CurePSP Elects Longtime Board and Community Member as Its Board Chair - Vimarsana News

CurePSP Elects Longtime Board and Community Member as Its Board Chair

CurePSP, the leading research and advocacy nonprofit organization for PSP, CBD and MSA, has elected F. Jackson (Jack) Phillips as the next Chair of the nonprofit's Board of Directors. Phillips will work closely with CurePSP's executive director and chief science officer, Kristophe Diaz, PhD, and the Board, to advance CurePSP's mission and strategic objectives.

Source: yahoo.com
Etosha Cave - Vimarsana News

Etosha Cave

Etosha Cave's startup Twelve opened the first commercial-grade facility for producing sustainable aviation fuel made from CO2 and water.

Source: cnbc.com
First AI Officer Named, as New Technology Challenges U.S. Justice Department - Vimarsana News

First AI Officer Named, as New Technology Challenges U.S. Justice Department

Jonathan Mayer, an assistant professor at Princeton University specializing in national security, consumer privacy, and criminal procedures, has been appointed Chief AI Officer. Read more.

Arch Biopartners Has Pre-IND Meeting With FDA to Discuss Repurposing Cilastatin as a New Treatment to Prevent Acute Kidney Injury - Vimarsana News

Arch Biopartners Has Pre-IND Meeting With FDA to Discuss Repurposing Cilastatin as a New Treatment to Prevent Acute Kidney Injury

TORONTO, Feb. 27, 2024 -- Arch Biopartners Inc., , announced today that it had a pre-investigational new drug application meeting with the U.S. Food and Drug Administration Division of...